Recombinant Human SLC22A5 Protein，His

SLC22A5, also known as the carnitine transporter OCTN2, plays a crucial role in the cellular uptake of carnitine, a vital molecule for fatty acid oxidation and energy production. Mutations in the SLC22A5 gene can lead to primary carnitine deficiency, a metabolic disorder characterized by impaired fatty acid metabolism, muscle weakness, hypoglycemia, and cardiomyopathy. Given its significant impact on health, researchers have focused on characterizing and producing recombinant SLC22A5 protein to better understand its molecular structure, transport mechanisms, and interactions with substrates and inhibitors. The expression of SLC22A5 in heterologous systems, such as yeast or mammalian cells, allows for the generation of functionally active protein for detailed biochemical analyses. These studies not only enhance our comprehension of the physiological role of SLC22A5 in carnitine transport but also pave the way for potential therapeutic interventions in related metabolic disorders. Furthermore, understanding the structure-function relationship of SLC22A5 can aid in drug design to modulate its activity or to develop treatment strategies for individuals with SLC22A5-related conditions. Overall, research on recombinant SLC22A5 is pivotal for unraveling the complexities of carnitine transport and its implications for human health.